CNRS-UMR8199, Lille Pasteur Institute, Lille 59000, France; Lille University, Lille 59000, France; European Genomic Institute for Diabetes (EGID), Lille 59000, France.
CNRS-UMR8199, Lille Pasteur Institute, Lille 59000, France; Lille University, Lille 59000, France; European Genomic Institute for Diabetes (EGID), Lille 59000, France; Department of Genomics of Common Disease, School of Public Health, Imperial College London, Hammersmith Hospital, London W12 0NN, UK.
Cell Metab. 2015 Mar 3;21(3):357-68. doi: 10.1016/j.cmet.2014.12.020. Epub 2015 Jan 29.
Type 2 diabetes (T2D) had long been referred to as the "geneticist's nightmare." Genome-wide association studies have fully confirmed the polygenic nature of T2D, demonstrating the role of many genes in T2D risk. The increasingly busier picture of T2D genetics is quite difficult to understand for the diabetes research community, which can create misunderstandings with geneticists, and can eventually limit both basic research and translational outcomes of these genetic discoveries. The present review wishes to lift the fog around genetics of T2D with the hope that it will foster integrated diabetes modeling approaches from genetic defects to personalized medicine.
2 型糖尿病(T2D)长期以来一直被称为“遗传学家的噩梦”。全基因组关联研究充分证实了 T2D 的多基因性质,表明许多基因在 T2D 风险中起作用。T2D 遗传学日益复杂的情况让糖尿病研究界难以理解,这可能会导致与遗传学家产生误解,并最终限制这些遗传发现的基础研究和转化成果。本综述希望消除 T2D 遗传学的迷雾,希望它能够促进从遗传缺陷到个性化医学的综合糖尿病建模方法。